Latest Breaking News On - Pulmonary drug delivery - Page 1 : comparemela.com

The rise in the prevalence of major respiratory disorders is expected to drive the pulmonary drug delivery devices market during the forecast period.Wilmington, Delaware, United States, Nov. 23, 2023 (GLOBE NEWSWIRE) Transparency Market Research Inc. -The global pulmonary drug delivery devices market is projected to flourish at a CAGR of 4.7% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 49.5 billion is anticipated for the market in 2031. As of 2023, the demand for

United statesNikhil sawlaniBoehringer ingelheim gmbAsia pacificChiesi farmaceuticiKoninklijke philipsTeva pharmaceutical industries ltdAsk expert for the researchSunovion pharmaceuticals incBoehringer ingelheimMerck coTransparency market researchOmron corporationTransparency market research incMannkind corporationJabil circuit inc